Eli Lilly advertising spend, FY2025
Eli Lilly (LLY) reported $2.9B of advertising expense for the fiscal year ended Dec 31, 2025. That is 4.4% of revenue of $65.2B. Up 107.1% from FY2024. Formerly Lilly Eli and Lilly Eli & Co Et Al.
Key facts
- Ad spend is 2.6x its FY2020 level ($1.1B), in line with revenue (2.7x).
- FY2025 is the highest year on file, going back to FY2017.
- Largest increase +107.1% in FY2025; largest cut -22.0% in FY2022.
- Ad spend has risen 3 years in a row.
- Ad spend is 4.4% of revenue, about the same as 4.5% in FY2020.
- Eli Lilly spends more on advertising than 96% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is close to the median of 4.5%.
Ad spend by fiscal year
Ad spend as % of revenue
Ad spend in context, FY2025
Advertising was 26.1% of selling, general and administrative expense. Research and development spending was 4.6x advertising.
| Advertising | $2.9B | AdvertisingExpense |
|---|---|---|
| Selling, general and administrative | $11.1B | ad spend = 26.1% |
| Research and development | $13.3B | R&D = 4.6x ad spend |
| Net income | $20.6B |
Same fiscal year and filing as the ad spend. Selling and marketing and SG&A usually include advertising.
History
Download CSV| Fiscal year | Period end | Ad spend | YoY | Revenue | Ad / revenue | Tag | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.9B | +107.1% | $65.2B | 4.4% | AdvertisingExpense | 10-K Feb 12, 2026 |
| FY2024 | Dec 31, 2024 | $1.4B | +27.3% | $45B | 3.1% | AdvertisingExpense | 10-K Feb 12, 2026 |
| FY2023 | Dec 31, 2023 | $1.1B | +13.8% | $34.1B | 3.2% | AdvertisingExpense | 10-K Feb 12, 2026 |
| FY2022 | Dec 31, 2022 | $967M | -22.0% | $28.5B | 3.4% | AdvertisingExpense | 10-K Feb 19, 2025 |
| FY2021 | Dec 31, 2021 | $1.2B | +12.7% | $28.3B | 4.4% | AdvertisingExpense | 10-K Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | $1.1B | 0.0% | $24.5B | 4.5% | AdvertisingExpense | 10-K Feb 22, 2023 |
| FY2019 | Dec 31, 2019 | $1.1B | +22.2% | $22.3B | 4.9% | AdvertisingExpense | 10-K Feb 23, 2022 |
| FY2018 | Dec 31, 2018 | $900M | +28.6% | $21.5B | 4.2% | AdvertisingExpense | 10-K Feb 17, 2021 |
| FY2017 | Dec 31, 2017 | $700M | n/a | $20B | 3.5% | AdvertisingExpense | 10-K Feb 19, 2020 |
Ad spend, revenue and the ratio come from the linked filing. YoY compares each year with the fiscal year directly before it, under the same tag. A gap, a change of tag or a change of fiscal year end leaves it blank.
What the figure is
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Compared with similar spenders
The 6 companies closest to Eli Lilly in latest-year ad spend.
| Rank | Company | Ad spend | Ad / revenue | YoY | Fiscal year |
|---|---|---|---|---|---|
| 19 | PepsiCo | $3.4B | 3.6% | -12.8% | FY2025 |
| 20 | AT&T | $3.1B | 2.5% | +24.0% | FY2025 |
| 21 | Eli Lilly | $2.9B | 4.4% | +107.1% | FY2025 |
| 22 | Colgate-Palmolive | $2.7B | 13.3% | -0.6% | FY2025 |
| 23 | Ford | $2.7B | 1.4% | -3.6% | FY2025 |
| 24 | Microsoft | $2.7B | 0.8% | +28.6% | FY2026 |
| 25 | Pfizer | $2.7B | 4.3% | -18.2% | FY2025 |
Questions
How much does Eli Lilly spend on advertising?
Eli Lilly spent $2.9B on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 12, 2026.
What percentage of revenue does Eli Lilly spend on advertising?
4.4% of revenue in fiscal 2025 ($2.9B against $65.2B). The median across the 458 companies tracked is 4.5%.
Is Eli Lilly spending more on advertising?
Yes. Ad spend rose 107.1% in fiscal 2025 from fiscal 2024. It has risen 3 years in a row.
How does Eli Lilly rank by advertising spend?
#21 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.
Does Eli Lilly spend more on advertising than on R&D?
No. In fiscal 2025 it spent $13.3B on research and development and $2.9B on advertising.
What does Eli Lilly's advertising figure include?
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Company and source
- Filing
- 10-K for FY2025, filed Feb 12, 2026
- Accession number
0000059478-26-000013- Company
- ELI LILLY & Co, CIK 59478, SIC 2834 (Pharmaceutical Preparations)
- Former names
- Lilly Eli, Lilly Eli & Co Et Al
- Headquarters
- Indianapolis, IN
- Incorporated in
- IN
- Fiscal year ends
- December 31
- Listed on
- NYSE
- SEC filer status
- Large accelerated filer
- Data
- SEC EDGAR XBRL company facts, retrieved Nov 18, 2026. Methodology.
- Cite
- Eli Lilly advertising spend, FY2017-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 12, 2026), retrieved Nov 18, 2026. https://io.trudov.com/company/eli-lilly/advertising-spend/
- Download
- CSV, all years · CSV, all 458 companies